health
Dec 30, 2022 2:57 p.m. 1 minute
Reuters exclusively announced that drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices for more than 350 unique drugs in the United States in early January. The hikes are expected to come as the industry prepares for the Biden administration’s anti-inflation bill, which will allow the government to directly negotiate the prices of some drugs beginning in 2026.
article tags
Topics of interest: health
Type: Reuters best
Sectors: Pharma & Healthcare
Regions: North America
Countries: US
Types of prizes: exclusivity
Story Types: Exclusive / Scoop
Media Types: text
Impact on the customer: Significant National History
A sign with the company logo is located on March 17, 2024 outside the headquarters…
The Eli Lilly Biotechnology Center was shown on March 1, 2023 in San Diego, California.Mike…
The Kalshi logo arranged on Monday, February 10, 2025, on a laptop in New York,…
Eli Lilly And Novo Nordisk Prepare to bring their rivalry to the next border of…
Apart from reporting that the Royals were in the arms about Harry's book, Spare was…
Chuck Schumer (D-NY) of the US Senate reduce speaks to reporters when the Senate's democratic…
This website uses cookies.